chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia, Swelling face
Clinical narrative: numbness and tingling; numbness and tingling; swelling on the face; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HYPOAESTHESIA (numbness and tingling), PARAESTHESIA (numbness and tingling) and SWELLING FACE (swelling on the face) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 11M20A and 027L20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (numbness and tingling), PARAESTHESIA (numbness and tingling) and SWELLING FACE (swelling on the face). At the time of the report, HYPOAESTHESIA (numbness and tingling) and PARAESTHESIA (numbness and tingling) outcome was unknown and SWELLING FACE (swelling on the face) had resolved.            No concomitant medications were provided. No treatment drugs were reported.
Sex: F
Vaccine: COVID19
Symptoms: Menstruation delayed
Clinical narrative: Missed/Delayed period; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MENSTRUATION DELAYED (Missed/Delayed period) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MENSTRUATION DELAYED (Missed/Delayed period). At the time of the report, MENSTRUATION DELAYED (Missed/Delayed period) outcome was unknown.            No relevant concomitant medications reported. No treatment information was provided. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Poor quality product administered, Wrong technique in product usage process
Clinical narrative: did not leave at room temperature for 15 minutes prior to drawing up the doses; frost-like ring on the bottom of the vial, 5 patients received doses; This spontaneous case was reported by a physician and describes the occurrence of WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (did not leave at room temperature for 15 minutes prior to drawing up the doses) and POOR QUALITY PRODUCT ADMINISTERED (frost-like ring on the bottom of the vial, 5 patients received doses) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, the patient experienced WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (did not leave at room temperature for 15 minutes prior to drawing up the doses) and POOR QUALITY PRODUCT ADMINISTERED (frost-like ring on the bottom of the vial, 5 patients received doses). At the time of the report, WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (did not leave at room temperature for 15 minutes prior to drawing up the doses) and POOR QUALITY PRODUCT ADMINISTERED (frost-like ring on the bottom of the vial, 5 patients received doses) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to US-MODERNATX, INC.-MOD-2021-095367, US-MODERNATX, INC.-MOD-2021-095302, US-MODERNATX, INC.-MOD-2021-095633 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-095367: US-MODERNATX, INC.-MOD-2021-095302: US-MODERNATX, INC.-MOD-2021-095633:
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Arthritis, Hypersomnia, Myalgia, Pain in extremity
Clinical narrative: Toes and both thumbs hurting; Joint pain,excruciating pain all over joints, hips started to hurt, toes,ankles, knees, and hips hurt; excruciating pain all over muscles and joints; Felt very sluggish; Slept a lot; joint inflammation,hips started to hurt; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRITIS (joint inflammation,hips started to hurt), SLUGGISHNESS (Felt very sluggish), HYPERSOMNIA (Slept a lot), PAIN IN EXTREMITY (Toes and both thumbs hurting) and MYALGIA (excruciating pain all over muscles and joints) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Osteoarthritis (Had surgery years ago on her feet.). Concurrent medical conditions included Drug allergy (Allergic to codeine.). Concomitant products included CARVEDILOL and AMLODIPINE for Blood pressure, VITAMIN D [VITAMIN D NOS] for an unknown indication.    On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced ARTHRITIS (joint inflammation,hips started to hurt). On 04-Apr-2021, the patient experienced SLUGGISHNESS (Felt very sluggish) and HYPERSOMNIA (Slept a lot). On 05-Apr-2021, the patient experienced MYALGIA (excruciating pain all over muscles and joints). On an unknown date, the patient experienced PAIN IN EXTREMITY (Toes and both thumbs hurting) and ARTHRALGIA (Joint pain,excruciating pain all over joints, hips started to hurt, toes,ankles, knees, and hips hurt). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ARTHRITIS (joint inflammation,hips started to hurt) and ARTHRALGIA (Joint pain,excruciating pain all over joints, hips started to hurt, toes,ankles, knees, and hips hurt) had not resolved and SLUGGISHNESS (Felt very sluggish), HYPERSOMNIA (Slept a lot), PAIN IN EXTREMITY (Toes and both thumbs hurting) and MYALGIA (excruciating pain all over muscles and joints) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD21-083788 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Follow up received on 20-JUL-2021 : Event (Joint pain) outcome was updated.; Sender's Comments:  MOD21-083788:Sisters case
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Sluggishness
Clinical narrative: Toes and both thumbs hurting; Joint pain,excruciating pain all over joints, hips started to hurt, toes,ankles, knees, and hips hurt; excruciating pain all over muscles and joints; Felt very sluggish; Slept a lot; joint inflammation,hips started to hurt; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRITIS (joint inflammation,hips started to hurt), SLUGGISHNESS (Felt very sluggish), HYPERSOMNIA (Slept a lot), PAIN IN EXTREMITY (Toes and both thumbs hurting) and MYALGIA (excruciating pain all over muscles and joints) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Osteoarthritis (Had surgery years ago on her feet.). Concurrent medical conditions included Drug allergy (Allergic to codeine.). Concomitant products included CARVEDILOL and AMLODIPINE for Blood pressure, VITAMIN D [VITAMIN D NOS] for an unknown indication.    On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced ARTHRITIS (joint inflammation,hips started to hurt). On 04-Apr-2021, the patient experienced SLUGGISHNESS (Felt very sluggish) and HYPERSOMNIA (Slept a lot). On 05-Apr-2021, the patient experienced MYALGIA (excruciating pain all over muscles and joints). On an unknown date, the patient experienced PAIN IN EXTREMITY (Toes and both thumbs hurting) and ARTHRALGIA (Joint pain,excruciating pain all over joints, hips started to hurt, toes,ankles, knees, and hips hurt). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ARTHRITIS (joint inflammation,hips started to hurt) and ARTHRALGIA (Joint pain,excruciating pain all over joints, hips started to hurt, toes,ankles, knees, and hips hurt) had not resolved and SLUGGISHNESS (Felt very sluggish), HYPERSOMNIA (Slept a lot), PAIN IN EXTREMITY (Toes and both thumbs hurting) and MYALGIA (excruciating pain all over muscles and joints) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD21-083788 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Follow up received on 20-JUL-2021 : Event (Joint pain) outcome was updated.; Sender's Comments:  MOD21-083788:Sisters case
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: pain in the arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in the arm) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     No medical history reported by reporter.  Concomitant products included VITAMINS NOS, VITAMIN D3 and MAGNESIUM for an unknown indication.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (pain in the arm). At the time of the report, PAIN IN EXTREMITY (pain in the arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no treatment reported.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Skin discolouration
Clinical narrative: strange discoloration more like a blister on their right hand; woke up today with a strange discoloration more like a blister on their right hand; This spontaneous case was reported by a consumer and describes the occurrence of BLISTER (strange discoloration more like a blister on their right hand) and SKIN DISCOLOURATION (woke up today with a strange discoloration more like a blister on their right hand) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, the patient experienced BLISTER (strange discoloration more like a blister on their right hand) and SKIN DISCOLOURATION (woke up today with a strange discoloration more like a blister on their right hand). At the time of the report, BLISTER (strange discoloration more like a blister on their right hand) and SKIN DISCOLOURATION (woke up today with a strange discoloration more like a blister on their right hand) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the event was not applicable. Relevant concomitant medications included Blood pressure pills.  Treatment information was not provided.
Age: 20.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Product administration error
Clinical narrative: 1st dose of Pfizer was taken / 2nd dose of moderna was taken; This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT ADMINISTRATION ERROR (1st dose of Pfizer was taken / 2nd dose of moderna was taken) in a 20-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination.    No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) at an unspecified dose. On 28-Apr-2021, the patient experienced PRODUCT ADMINISTRATION ERROR (1st dose of Pfizer was taken / 2nd dose of moderna was taken). At the time of the report, PRODUCT ADMINISTRATION ERROR (1st dose of Pfizer was taken / 2nd dose of moderna was taken) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported by investigator  No treatment medications provided by the reporter.
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Hot flush
Clinical narrative: Dizziness; Hot flashes; This spontaneous case was reported by a physician and describes the occurrence of DIZZINESS (Dizziness) and HOT FLUSH (Hot flashes) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizziness) and HOT FLUSH (Hot flashes). At the time of the report, DIZZINESS (Dizziness) and HOT FLUSH (Hot flashes) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication provided by the reporter no treatment information provided by the reporter   This case was linked to US-MODERNATX, INC.-MOD-2021-095268, US-MODERNATX, INC.-MOD-2021-094933 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-095268: US-MODERNATX, INC.-MOD-2021-094933:
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Mobility decreased, Myalgia, Vaccination complication
Clinical narrative: side effects were worse after the 2nd dose; She was unable to move due to the pain; Pain all over body; This spontaneous case was reported by a consumer and describes the occurrence of MOBILITY DECREASED (She was unable to move due to the pain), VACCINATION COMPLICATION (side effects were worse after the 2nd dose) and MYALGIA (Pain all over body) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036821A) for COVID-19 vaccination.     The patient's past medical history included Radiotherapy (radiation treatment). Concurrent medical conditions included Cancer and Asthma. Concomitant products included GABAPENTIN and VERAPAMIL for an unknown indication.   On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MOBILITY DECREASED (She was unable to move due to the pain). On an unknown date, the patient experienced VACCINATION COMPLICATION (side effects were worse after the 2nd dose) and MYALGIA (Pain all over body). At the time of the report, MOBILITY DECREASED (She was unable to move due to the pain) had not resolved and VACCINATION COMPLICATION (side effects were worse after the 2nd dose) and MYALGIA (Pain all over body) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported by investigator  No treatment medications provided by the reporter.   Patient stated that the pain has continued for three weeks after the administration of the 2nd dose. She also stated that the side effects were worse after the 2nd dose of the Moderna COVID-19 vaccine. She is scheduled to go to the hospital on Monday, 3May2021, for her cancer condition. She wanted to know if her underlying conditions and radiation treatments exacerbate the pain experienced after taking the Moderna COVID-19 vaccine and whether she get COVID-19 after receiving the vaccine   This case was linked to MOD-2021-095188 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: Follow-up information TCR received on 28-MAY-2021, patient declined further follow up and stated that she felt Moderna vaccine did a lot of permanent damage to a lot of people.
Sex: U
Vaccine: COVID19
Symptoms: Blood test, Hepatic enzyme increased, Ultrasound scan
Clinical narrative: elevated liver enzymes; This spontaneous case was reported by a consumer and describes the occurrence of HEPATIC ENZYME INCREASED (elevated liver enzymes) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR) for an unknown indication.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HEPATIC ENZYME INCREASED (elevated liver enzymes). At the time of the report, HEPATIC ENZYME INCREASED (elevated liver enzymes) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Apr-2021, Blood test: unknown (abnormal) Hepatic enzymes elevated. On 26-Apr-2021, Ultrasound scan: unknown (Inconclusive) Unknown.         No concomitant medications reported by investigator   This case was linked to MOD-2021-042851 (Patient Link).
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Apr-2021, the patient experienced VACCINATION SITE PAIN (sore arm). On 25-Apr-2021, VACCINATION SITE PAIN (sore arm) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information include Painkillers with a sleep aid for treatment of sore arm.  No concomitant medication reported
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Allergy to vaccine, Chills, Eye swelling, Head discomfort, Lymphadenopathy
Clinical narrative: chills and lot's of cold; got an eye lip swollen like with an allergic reaction; started to get the upper lip, the lip and the cheek and part of the right nose swollen and on the; throat swollen; reaction to vaccine; feels on top of the head like pressure; Swollen lymph nodes on the right side; chills and lot's of cold; body aches really strong/body aches; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (chills and lot's of cold), EYE SWELLING (got an eye lip swollen like with an allergic reaction), SWELLING FACE (started to get the upper lip, the lip and the cheek and part of the right nose swollen and on the), PHARYNGEAL SWELLING (throat swollen) and ALLERGY TO VACCINE (reaction to vaccine) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046A21A and 047B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included VITAMINS NOS and VITAMIN D3 for an unknown indication.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (chills and lot's of cold), EYE SWELLING (got an eye lip swollen like with an allergic reaction), SWELLING FACE (started to get the upper lip, the lip and the cheek and part of the right nose swollen and on the), PHARYNGEAL SWELLING (throat swollen), ALLERGY TO VACCINE (reaction to vaccine), HEAD DISCOMFORT (feels on top of the head like pressure), LYMPHADENOPATHY (Swollen lymph nodes on the right side), CHILLS (chills and lot's of cold) and MYALGIA (body aches really strong/body aches). The patient was treated with FEXOFENADINE HYDROCHLORIDE (ALLEGRA) at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. At the time of the report, NASOPHARYNGITIS (chills and lot's of cold), EYE SWELLING (got an eye lip swollen like with an allergic reaction), SWELLING FACE (started to get the upper lip, the lip and the cheek and part of the right nose swollen and on the), PHARYNGEAL SWELLING (throat swollen), ALLERGY TO VACCINE (reaction to vaccine), HEAD DISCOMFORT (feels on top of the head like pressure), LYMPHADENOPATHY (Swollen lymph nodes on the right side), CHILLS (chills and lot's of cold) and MYALGIA (body aches really strong/body aches) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-095205 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: No specific follow-up information recorded.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nasopharyngitis, Pharyngeal swelling, Swelling face
Clinical narrative: chills and lot's of cold; got an eye lip swollen like with an allergic reaction; started to get the upper lip, the lip and the cheek and part of the right nose swollen and on the; throat swollen; reaction to vaccine; feels on top of the head like pressure; Swollen lymph nodes on the right side; chills and lot's of cold; body aches really strong/body aches; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (chills and lot's of cold), EYE SWELLING (got an eye lip swollen like with an allergic reaction), SWELLING FACE (started to get the upper lip, the lip and the cheek and part of the right nose swollen and on the), PHARYNGEAL SWELLING (throat swollen) and ALLERGY TO VACCINE (reaction to vaccine) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046A21A and 047B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included VITAMINS NOS and VITAMIN D3 for an unknown indication.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (chills and lot's of cold), EYE SWELLING (got an eye lip swollen like with an allergic reaction), SWELLING FACE (started to get the upper lip, the lip and the cheek and part of the right nose swollen and on the), PHARYNGEAL SWELLING (throat swollen), ALLERGY TO VACCINE (reaction to vaccine), HEAD DISCOMFORT (feels on top of the head like pressure), LYMPHADENOPATHY (Swollen lymph nodes on the right side), CHILLS (chills and lot's of cold) and MYALGIA (body aches really strong/body aches). The patient was treated with FEXOFENADINE HYDROCHLORIDE (ALLEGRA) at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. At the time of the report, NASOPHARYNGITIS (chills and lot's of cold), EYE SWELLING (got an eye lip swollen like with an allergic reaction), SWELLING FACE (started to get the upper lip, the lip and the cheek and part of the right nose swollen and on the), PHARYNGEAL SWELLING (throat swollen), ALLERGY TO VACCINE (reaction to vaccine), HEAD DISCOMFORT (feels on top of the head like pressure), LYMPHADENOPATHY (Swollen lymph nodes on the right side), CHILLS (chills and lot's of cold) and MYALGIA (body aches really strong/body aches) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-095205 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: No specific follow-up information recorded.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Eye swelling, Hypoaesthesia, Hypoaesthesia oral, Paraesthesia, Paraesthesia oral
Clinical narrative: swelling of the left eye; mild numbness and tingling on the left side of the lower lip; numbness and tingling of the throat; numbness and tingling of the throat; mild numbness and tingling on the left side of the lower lip; numbness and tingling of the hand; swelling on the left side of the face; numbness and tingling of the hand; This spontaneous case was reported by a consumer and describes the occurrence of EYE SWELLING (swelling of the left eye), PARAESTHESIA ORAL (mild numbness and tingling on the left side of the lower lip), PHARYNGEAL PARAESTHESIA (numbness and tingling of the throat), PHARYNGEAL HYPOAESTHESIA (numbness and tingling of the throat) and HYPOAESTHESIA ORAL (mild numbness and tingling on the left side of the lower lip) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B214) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History was Reported.  Concomitant products included L-lysine                                                       for herpes simplex virus for an unknown indication.    On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, the patient experienced EYE SWELLING (swelling of the left eye), PARAESTHESIA ORAL (mild numbness and tingling on the left side of the lower lip), PHARYNGEAL PARAESTHESIA (numbness and tingling of the throat), PHARYNGEAL HYPOAESTHESIA (numbness and tingling of the throat), HYPOAESTHESIA ORAL (mild numbness and tingling on the left side of the lower lip), PARAESTHESIA (numbness and tingling of the hand), SWELLING FACE (swelling on the left side of the face) and HYPOAESTHESIA (numbness and tingling of the hand). At the time of the report, EYE SWELLING (swelling of the left eye), PARAESTHESIA ORAL (mild numbness and tingling on the left side of the lower lip), PHARYNGEAL PARAESTHESIA (numbness and tingling of the throat), PHARYNGEAL HYPOAESTHESIA (numbness and tingling of the throat), HYPOAESTHESIA ORAL (mild numbness and tingling on the left side of the lower lip), PARAESTHESIA (numbness and tingling of the hand), SWELLING FACE (swelling on the left side of the face) and HYPOAESTHESIA (numbness and tingling of the hand) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   treatment information include Benadryl 50mg around 9pm, and 25 mg at midnight (April 27,2021)
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Pharyngeal hypoaesthesia, Pharyngeal paraesthesia, Swelling face
Clinical narrative: swelling of the left eye; mild numbness and tingling on the left side of the lower lip; numbness and tingling of the throat; numbness and tingling of the throat; mild numbness and tingling on the left side of the lower lip; numbness and tingling of the hand; swelling on the left side of the face; numbness and tingling of the hand; This spontaneous case was reported by a consumer and describes the occurrence of EYE SWELLING (swelling of the left eye), PARAESTHESIA ORAL (mild numbness and tingling on the left side of the lower lip), PHARYNGEAL PARAESTHESIA (numbness and tingling of the throat), PHARYNGEAL HYPOAESTHESIA (numbness and tingling of the throat) and HYPOAESTHESIA ORAL (mild numbness and tingling on the left side of the lower lip) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B214) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History was Reported.  Concomitant products included L-lysine                                                       for herpes simplex virus for an unknown indication.    On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, the patient experienced EYE SWELLING (swelling of the left eye), PARAESTHESIA ORAL (mild numbness and tingling on the left side of the lower lip), PHARYNGEAL PARAESTHESIA (numbness and tingling of the throat), PHARYNGEAL HYPOAESTHESIA (numbness and tingling of the throat), HYPOAESTHESIA ORAL (mild numbness and tingling on the left side of the lower lip), PARAESTHESIA (numbness and tingling of the hand), SWELLING FACE (swelling on the left side of the face) and HYPOAESTHESIA (numbness and tingling of the hand). At the time of the report, EYE SWELLING (swelling of the left eye), PARAESTHESIA ORAL (mild numbness and tingling on the left side of the lower lip), PHARYNGEAL PARAESTHESIA (numbness and tingling of the throat), PHARYNGEAL HYPOAESTHESIA (numbness and tingling of the throat), HYPOAESTHESIA ORAL (mild numbness and tingling on the left side of the lower lip), PARAESTHESIA (numbness and tingling of the hand), SWELLING FACE (swelling on the left side of the face) and HYPOAESTHESIA (numbness and tingling of the hand) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   treatment information include Benadryl 50mg around 9pm, and 25 mg at midnight (April 27,2021)
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Full blood count, Night sweats, Tuberculin test, Ultrasound Doppler, X-ray
Clinical narrative: Night sweats; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of NIGHT SWEATS (Night sweats) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042L20A and 030M20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Allergy to Benadryl), Ulcer, Blood pressure, AFib and Enlarged prostate. Concomitant products included METOPROLOL SUCCINATE and PROPAFENONE HCL for AFib, ATORVASTATIN from 04-Apr-2020 to an unknown date for Blood pressure, TAMSULOSIN HYDROCHLORIDE (TAMSULOSIN [TAMSULOSIN HYDROCHLORIDE]) for Enlarged prostate, OMEPRAZOLE from 15-Nov-2020 to an unknown date for Ulcer.   On 17-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced NIGHT SWEATS (Night sweats). At the time of the report, NIGHT SWEATS (Night sweats) had not resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Full blood count: normal (normal) Normal. On an unknown date, Tuberculin test: normal (normal) normal. On an unknown date, Ultrasound Doppler: normal (normal) normal. On an unknown date, X-ray: normal (normal) Normal.         No treatment was reported.  Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-095204 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: Follow up Received: Added Patient demographics, Medical History, Lab data, Suspect Drug Onset date, Concomitant Medications, Event Outcome.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: itching ears; itching; soreness; bump; redness; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching ears), VACCINATION SITE PRURITUS (itching), VACCINATION SITE PAIN (soreness), VACCINATION SITE SWELLING (bump) and VACCINATION SITE ERYTHEMA (redness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC) for an unknown indication.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, the patient experienced PRURITUS (itching ears), VACCINATION SITE PRURITUS (itching), VACCINATION SITE PAIN (soreness), VACCINATION SITE SWELLING (bump) and VACCINATION SITE ERYTHEMA (redness). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, PRURITUS (itching ears), VACCINATION SITE PRURITUS (itching), VACCINATION SITE PAIN (soreness), VACCINATION SITE SWELLING (bump) and VACCINATION SITE ERYTHEMA (redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication include blood pressure medication.  Treatment medication include Benadryl.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Breast mass, Chills, Erythema, Feeling abnormal, Feeling hot
Clinical narrative: Arm red and swollen; Lump in right breast; Feeling hot; Soreness in the legs; Swelling of the lymph nodes in the same arm of the injection; Arm red and swollen; Fever; Chills; Fell like a ball; Cramps on  legs; Bad body aches; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (Cramps on  legs), SWELLING (Arm red and swollen), FEELING ABNORMAL (Fell like a ball), ERYTHEMA (Arm red and swollen) and BREAST MASS (Lump in right breast) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002B21A and 008C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Seasonal allergy. Concomitant products included CETIRIZINE for Seasonal allergy.   On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Apr-2021, the patient experienced MYALGIA (Bad body aches). On 27-Apr-2021, the patient experienced MUSCLE SPASMS (Cramps on  legs). On 28-Apr-2021, the patient experienced FEELING ABNORMAL (Fell like a ball). On an unknown date, the patient experienced SWELLING (Arm red and swollen), ERYTHEMA (Arm red and swollen), BREAST MASS (Lump in right breast), FEELING HOT (Feeling hot), PAIN IN EXTREMITY (Soreness in the legs), VACCINATION SITE LYMPHADENOPATHY (Swelling of the lymph nodes in the same arm of the injection), PYREXIA (Fever) and CHILLS (Chills). At the time of the report, MUSCLE SPASMS (Cramps on  legs), SWELLING (Arm red and swollen), FEELING ABNORMAL (Fell like a ball), ERYTHEMA (Arm red and swollen), BREAST MASS (Lump in right breast), FEELING HOT (Feeling hot), PAIN IN EXTREMITY (Soreness in the legs), VACCINATION SITE LYMPHADENOPATHY (Swelling of the lymph nodes in the same arm of the injection), MYALGIA (Bad body aches), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Ultrasound scan: abnormal (abnormal) Lump was still there.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information include Ibuprofen on 25 and 26 April2021.   This case was linked to US-MODERNATX, INC.-MOD-2021-095066 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 01-Aug-2021: Follow-up received on 01 Aug 2021, added current condition, lab data, second dose batch number,concomitant drug and events.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-095066:dose 2
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle spasms, Myalgia, Pain in extremity, Pyrexia, Swelling
Clinical narrative: Arm red and swollen; Lump in right breast; Feeling hot; Soreness in the legs; Swelling of the lymph nodes in the same arm of the injection; Arm red and swollen; Fever; Chills; Fell like a ball; Cramps on  legs; Bad body aches; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (Cramps on  legs), SWELLING (Arm red and swollen), FEELING ABNORMAL (Fell like a ball), ERYTHEMA (Arm red and swollen) and BREAST MASS (Lump in right breast) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002B21A and 008C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Seasonal allergy. Concomitant products included CETIRIZINE for Seasonal allergy.   On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Apr-2021, the patient experienced MYALGIA (Bad body aches). On 27-Apr-2021, the patient experienced MUSCLE SPASMS (Cramps on  legs). On 28-Apr-2021, the patient experienced FEELING ABNORMAL (Fell like a ball). On an unknown date, the patient experienced SWELLING (Arm red and swollen), ERYTHEMA (Arm red and swollen), BREAST MASS (Lump in right breast), FEELING HOT (Feeling hot), PAIN IN EXTREMITY (Soreness in the legs), VACCINATION SITE LYMPHADENOPATHY (Swelling of the lymph nodes in the same arm of the injection), PYREXIA (Fever) and CHILLS (Chills). At the time of the report, MUSCLE SPASMS (Cramps on  legs), SWELLING (Arm red and swollen), FEELING ABNORMAL (Fell like a ball), ERYTHEMA (Arm red and swollen), BREAST MASS (Lump in right breast), FEELING HOT (Feeling hot), PAIN IN EXTREMITY (Soreness in the legs), VACCINATION SITE LYMPHADENOPATHY (Swelling of the lymph nodes in the same arm of the injection), MYALGIA (Bad body aches), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Ultrasound scan: abnormal (abnormal) Lump was still there.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information include Ibuprofen on 25 and 26 April2021.   This case was linked to US-MODERNATX, INC.-MOD-2021-095066 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 01-Aug-2021: Follow-up received on 01 Aug 2021, added current condition, lab data, second dose batch number,concomitant drug and events.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-095066:dose 2
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Ultrasound scan, Vaccination site lymphadenopathy
Clinical narrative: Arm red and swollen; Lump in right breast; Feeling hot; Soreness in the legs; Swelling of the lymph nodes in the same arm of the injection; Arm red and swollen; Fever; Chills; Fell like a ball; Cramps on  legs; Bad body aches; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (Cramps on  legs), SWELLING (Arm red and swollen), FEELING ABNORMAL (Fell like a ball), ERYTHEMA (Arm red and swollen) and BREAST MASS (Lump in right breast) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002B21A and 008C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Seasonal allergy. Concomitant products included CETIRIZINE for Seasonal allergy.   On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Apr-2021, the patient experienced MYALGIA (Bad body aches). On 27-Apr-2021, the patient experienced MUSCLE SPASMS (Cramps on  legs). On 28-Apr-2021, the patient experienced FEELING ABNORMAL (Fell like a ball). On an unknown date, the patient experienced SWELLING (Arm red and swollen), ERYTHEMA (Arm red and swollen), BREAST MASS (Lump in right breast), FEELING HOT (Feeling hot), PAIN IN EXTREMITY (Soreness in the legs), VACCINATION SITE LYMPHADENOPATHY (Swelling of the lymph nodes in the same arm of the injection), PYREXIA (Fever) and CHILLS (Chills). At the time of the report, MUSCLE SPASMS (Cramps on  legs), SWELLING (Arm red and swollen), FEELING ABNORMAL (Fell like a ball), ERYTHEMA (Arm red and swollen), BREAST MASS (Lump in right breast), FEELING HOT (Feeling hot), PAIN IN EXTREMITY (Soreness in the legs), VACCINATION SITE LYMPHADENOPATHY (Swelling of the lymph nodes in the same arm of the injection), MYALGIA (Bad body aches), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Ultrasound scan: abnormal (abnormal) Lump was still there.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information include Ibuprofen on 25 and 26 April2021.   This case was linked to US-MODERNATX, INC.-MOD-2021-095066 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 01-Aug-2021: Follow-up received on 01 Aug 2021, added current condition, lab data, second dose batch number,concomitant drug and events.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-095066:dose 2
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pain
Clinical narrative: terrible headache; hurting; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (terrible headache) and PAIN (hurting) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (terrible headache) and PAIN (hurting). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, HEADACHE (terrible headache) and PAIN (hurting) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication reported  Action taken with mRNA-1273 in response to the event was not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Neck pain
Clinical narrative: Traveling pain to neck; Shoulder pain; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (Traveling pain to neck) and ARTHRALGIA (Shoulder pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Apr-2021, the patient experienced NECK PAIN (Traveling pain to neck) and ARTHRALGIA (Shoulder pain). At the time of the report, NECK PAIN (Traveling pain to neck) and ARTHRALGIA (Shoulder pain) outcome was unknown.            No concomitant medications were reported. No treatment information was provided.   Reporter did not allow further contact
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site bruising, Vaccination site pain
Clinical narrative: Bruise at the injection site; Soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE BRUISING (Bruise at the injection site) and VACCINATION SITE PAIN (Soreness at the injection site) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     Concomitant products included SERTRALINE HYDROCHLORIDE (ZOLOFT), AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL), QUETIAPINE FUMARATE (SEROQUEL) and CLONAZEPAM for an unknown indication.    On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, the patient experienced VACCINATION SITE BRUISING (Bruise at the injection site) and VACCINATION SITE PAIN (Soreness at the injection site). The patient was treated with IBUPROFEN for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE BRUISING (Bruise at the injection site) and VACCINATION SITE PAIN (Soreness at the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient had no fever and a cyst was removed from opposite left arm on 23-Apr-2021. Treatment information also included Ice pack.